Montelukast Sodium
Brand name: Montelukast Sodium
Rank #186 of 500 drugs by total cost
$81.3M
Total Cost
5,086,706
Total Claims
$81.3M
Total Cost
84,070
Prescribers
$16
Cost per Claim
1,282,336
Beneficiaries
11,141,054
30-Day Fills
$967
Avg Cost/Provider
61
Avg Claims/Provider
About Montelukast Sodium
Montelukast Sodium (sold as Montelukast Sodium) was prescribed 5,086,706 times by 84,070 Medicare Part D providers in 2023, costing the program $81.3M. At $16 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 183 | Famotidine (Famotidine) | $84.3M | 5,257,365 |
| 184 | Mifepristone (Korlym) | $83.3M | 2,397 |
| 185 | Insulin Nph Hum/Reg Insulin Hm (Humulin 70-30) | $82.3M | 177,501 |
| 186 | Montelukast Sodium (Montelukast Sodium) | $81.3M | 5,086,706 |
| 187 | Certolizumab Pegol (Cimzia) | $79.9M | 11,784 |
| 188 | Celecoxib (Celecoxib) | $77.7M | 1,938,505 |
| 189 | Sod Phenylbutyrat/Taurursodiol (Relyvrio) | $77.0M | 6,152 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology